.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of California, Kikoko has shown a varied performance across different product categories. Notably, in the Beverages category, Kikoko maintained a steady presence, ranking between 17th and 18th from December 2023 to March 2024, indicating a consistent consumer preference but also room for growth. The brand's performance in the Capsules category is particularly impressive, improving its rank from 5th in December 2023 to 3rd by March 2024. This upward trajectory suggests a strong market acceptance and possibly superior product offerings in this segment. However, in the Edibles category, Kikoko's ranking fluctuated slightly but remained within the top 30, peaking at 25th in January 2024, which reflects a stable yet competitive position within this category.
Interestingly, Kikoko ventured into the Tincture & Sublingual category, where it was not ranked until February 2024, starting at a distant 54th position but making a significant jump to 40th by March 2024. Although starting from a lower base, this movement indicates a growing interest and potentially increasing market share in this new category for Kikoko. It's worth noting that despite these competitive rankings, Kikoko's sales in the Capsules category saw a notable increase, from $585,199 in December 2023 to $770,346 by March 2024, showcasing strong consumer demand and successful sales strategies. Across categories, Kikoko's performance highlights its strengths and areas for potential growth, with significant achievements in the Capsules category and promising developments in newer market segments like Tincture & Sublingual.
Competitive Landscape
In the competitive landscape of the cannabis capsules category in California, Kikoko has shown a notable upward trajectory in its ranking over the recent months, moving from fifth place in December 2023 to third place by March 2024. This rise in rank is indicative of Kikoko's growing market presence and consumer preference, as it outpaces competitors like ABX / AbsoluteXtracts, which saw a slight decline from third to fourth place in the same period, and Emerald Bay Extracts, which remained steady but below Kikoko in the rankings. However, Kikoko still trails behind the leaders in the category, Level and Breez, which have consistently held the first and second spots respectively. Level's dominance is particularly noteworthy, maintaining the top position with a significant lead in sales. Breez, while experiencing a slight dip in sales from December 2023 to February 2024, rebounded in March, indicating a strong competitive stance. Kikoko's upward movement in rank and sales suggests a positive consumer reception and a growing brand strength within the California cannabis capsules market, positioning it as a brand to watch in the ongoing competitive dynamics.
Notable Products
In Mar-2024, Kikoko's top-performing product was the XTabs - Indica High Dose Tablets 20-Pack (1000mg) from the Capsules category, marking a significant sales figure of 6991 units. Following closely, the XTabs - Sativa High Dose Tablets 20-Pack (1000mg) held the second position, while the XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) secured the third spot, both also in the Capsules category. Notably, the rankings for these top three products remained consistent from previous months, showcasing a stable consumer preference. The Little Helpers - CBN/THC/Melatonin 3:2:1 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) and Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) from the Edible category rounded out the top five, maintaining their positions as well. This analysis reveals Kikoko's dominance in the Capsules category and a steady market demand for their top products.
Top Selling Cannabis Brands
